ImmunoGen, Inc. (IMGN) Net Income (Loss) Attributable to Parent USD 2014 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
ImmunoGen, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2014 to 2023.
  • ImmunoGen, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2023 was $30.7 M.
  • ImmunoGen, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2023 was -$73.5 M, a 63.4% increase year-over-year.
  • ImmunoGen, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$223 M, a 60% decline from 2021.
  • ImmunoGen, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$139 M, a 214% decline from 2020.
  • ImmunoGen, Inc. annual Net Income (Loss) Attributable to Parent for 2020 was -$44.4 M, a 57.4% increase from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 -$73.5 M $30.7 M +$109 M Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 -$182 M -$4.25 M +$57.8 M +93.2% Apr 1, 2023 Jun 30, 2023 10-Q 2023-11-02
Q1 2023 -$240 M -$41 M -$16.9 M -69.9% Jan 1, 2023 Mar 31, 2023 10-Q 2023-11-02
Q4 2022 -$223 M -$59 M -$21.8 M -58.7% Oct 1, 2022 Dec 31, 2022 10-Q 2023-11-02
Q3 2022 -$201 M -$77.8 M -$40.4 M -108% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 -$161 M -$62 M -$31.3 M -102% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-02
Q1 2022 -$129 M -$24.1 M +$9.91 M +29.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-02
Q4 2021 -$139 M -$37.2 M -$68.6 M -218% Oct 1, 2021 Dec 31, 2021 10-Q 2022-11-04
Q3 2021 -$70.7 M -$37.3 M -$15 M -66.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 -$55.8 M -$30.7 M -$6.44 M -26.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-04
Q1 2021 -$49.3 M -$34.1 M -$4.96 M -17.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-04
Q4 2020 -$44.4 M $31.4 M +$26.6 M +552% Oct 1, 2020 Dec 31, 2020 10-Q 2021-10-29
Q3 2020 -$70.9 M -$22.4 M -$624 K -2.87% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-29
Q2 2020 -$70.3 M -$24.3 M +$19.1 M +44.1% Apr 1, 2020 Jun 30, 2020 10-Q 2021-10-29
Q1 2020 -$89.5 M -$29.1 M +$14.7 M +33.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-10-29
Q4 2019 -$104 M $4.81 M +$46.6 M Oct 1, 2019 Dec 31, 2019 10-Q 2020-11-06
Q3 2019 -$151 M -$21.8 M +$25.1 M +53.5% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 -$176 M -$43.4 M -$1.82 M -4.38% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-06
Q1 2019 -$174 M -$43.8 M -$5.14 M -13.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-06
Q4 2018 -$169 M -$41.8 M -$28.7 M -219% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-11
Q3 2018 -$140 M -$46.8 M +$9.88 M +17.4% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-11
Q2 2018 -$150 M -$41.6 M -$32.8 M -369% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-11
Q1 2018 -$117 M -$38.6 M -$21.3 M -123% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-11
Q4 2017 -$96 M -$13.1 M +$21 M +61.6% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-11
Q3 2017 -$117 M -$56.7 M -$12 M -26.7% Jul 1, 2017 Sep 30, 2017 10-K 2020-03-11
Q2 2017 -$105 M -$8.87 M +$37.1 M +80.7% Apr 1, 2017 Jun 30, 2017 10-K 2020-03-11
Q1 2017 -$142 M -$17.3 M +$14.6 M +45.7% Jan 1, 2017 Mar 31, 2017 10-K 2020-03-11
Q4 2016 -$157 M -$34.2 M -$925 K -2.78% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-01
Q3 2016 -$156 M -$44.7 M -$11 M -32.6% Jul 1, 2016 Sep 30, 2016 10-K 2019-03-01
Q2 2016 -$145 M -$45.9 M -$15.4 M -50.7% Apr 1, 2016 Jun 30, 2016 10-K 2019-03-01
Q1 2016 -$129 M -$31.9 M -$10.3 M -47.7% Jan 1, 2016 Mar 31, 2016 10-K 2019-03-01
Q4 2015 -$119 M -$33.2 M -$46.9 M -344% Oct 1, 2015 Dec 31, 2015 10-K 2019-03-01
Q3 2015 -$72.2 M -$33.7 M -$11.5 M -51.4% Jul 1, 2015 Sep 30, 2015 10-K 2019-03-01
Q2 2015 -$60.7 M -$30.5 M Apr 1, 2015 Jun 30, 2015 10-K 2018-03-07
Q1 2015 -$21.6 M Jan 1, 2015 Mar 31, 2015 10-K 2018-03-07
Q4 2014 $13.6 M Oct 1, 2014 Dec 31, 2014 10-K 2018-03-07
Q3 2014 -$22.3 M Jul 1, 2014 Sep 30, 2014 10-K 2018-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.